Literature DB >> 9332905

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.

U H Frommberger1, J Bauer, P Haselbauer, A Fräulin, D Riemann, M Berger.   

Abstract

The concentration of cytokines such as Interleukin-6 (IL-6) has been reported to be elevated in depressed and schizophrenic patients and, in healthy persons, upon stress. Interleukin-6 plasma levels were determined in depressed (n = 12) and schizophrenic (n = 32) patients during the acute state of illness and after remission at approximately 8 weeks after admission and were compared with healthy controls (n = 12). Patients were diagnosed according to DSM-III-R by the Structured Clinical Interview (SCID). Severity of illness was assessed for depression by the Montgomery Asberg Depression Rating Scale (MADRS) and for schizophrenia by the Brief Psychiatric Rating Scale (BPRS). Interleukin-6 plasma concentrations were elevated during the acute state either of depression or of schizophrenia if compared to controls. After remission, IL-6 concentrations in depressed and in schizophrenic patients had decreased and did not differ significantly from controls. We hypothesize that the elevated IL-6 levels during the acute state of depression or schizophrenia may reflect an unspecific stress response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9332905     DOI: 10.1007/bf02900219

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  30 in total

1.  Elevated levels of acute phase plasma proteins in major depression.

Authors:  P R Joyce; C R Hawes; R T Mulder; J D Sellman; D A Wilson; D R Boswell
Journal:  Biol Psychiatry       Date:  1992-12-01       Impact factor: 13.382

2.  The acute phase response: from Hippocrates to cytokine biology.

Authors:  I Kushner
Journal:  Eur Cytokine Netw       Date:  1991 Mar-Apr       Impact factor: 2.737

3.  Excretion of IL-6 by astronauts during spaceflight.

Authors:  T P Stein; M D Schluter
Journal:  Am J Physiol       Date:  1994-03

4.  Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine.

Authors:  A Słuzewska; J K Rybakowski; M Laciak; A Mackiewicz; M Sobieska; K Wiktorowicz
Journal:  Ann N Y Acad Sci       Date:  1995-07-21       Impact factor: 5.691

5.  The effects of psychological stress on plasma interleukin-6 activity in rats.

Authors:  L G LeMay; A J Vander; M J Kluger
Journal:  Physiol Behav       Date:  1990-05

6.  Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal axis in depression.

Authors:  M Maes; H Y Meltzer; W Stevens; P Cosyns; P Blockx
Journal:  Psychol Med       Date:  1994-02       Impact factor: 7.723

7.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.

Authors:  I L Campbell; C R Abraham; E Masliah; P Kemper; J D Inglis; M B Oldstone; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness.

Authors:  R Ganguli; Z Yang; G Shurin; K N Chengappa; J S Brar; A V Gubbi; B S Rabin
Journal:  Psychiatry Res       Date:  1994-01       Impact factor: 3.222

9.  Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers.

Authors:  M Maes; E Bosmans; J Calabrese; R Smith; H Y Meltzer
Journal:  J Psychiatr Res       Date:  1995 Mar-Apr       Impact factor: 4.791

10.  Changes of plasma concentrations of interleukin-1 alpha and interleukin-6 with neuroleptic treatment for schizophrenia.

Authors:  H M Xu; J Wei; G P Hemmings
Journal:  Br J Psychiatry       Date:  1994-02       Impact factor: 9.319

View more
  80 in total

Review 1.  Biobehavioral influences on cancer progression.

Authors:  Erin S Costanzo; Anil K Sood; Susan K Lutgendorf
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

2.  The influences of cytokines as a possible substrate for the psychological effects of immunomodulation therapy in multiple sclerosis.

Authors:  N N Spirin; D S Kasatkin
Journal:  Neurosci Behav Physiol       Date:  2009-01

3.  Immune system dysregulation in adolescent major depressive disorder.

Authors:  Vilma Gabbay; Rachel G Klein; Carmen M Alonso; James S Babb; Melissa Nishawala; Georgette De Jesus; Glenn S Hirsch; Pauline M Z Hottinger-Blanc; Charles J Gonzalez
Journal:  J Affect Disord       Date:  2008-09-13       Impact factor: 4.839

4.  Serotonin transporter gene: a new polymorphism may affect response to antidepressant treatments in major depressive disorder.

Authors:  Yoshihiko Matsumoto; Chiara Fabbri; Silvia Pellegrini; Stefano Porcelli; Pierluigi Politi; Silvio Bellino; Caterina Iofrida; Veronica Mariotti; Erika Melissari; Marco Menchetti; Valentina Martinelli; Marco Cappucciati; Paola Bozzatello; Elena Brignolo; Paolo Brambilla; Matteo Balestrieri; Alessandro Serretti
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

Review 5.  The inflammation hypothesis in geriatric depression.

Authors:  George S Alexopoulos; Sarah Shizuko Morimoto
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-02       Impact factor: 3.485

6.  Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders.

Authors:  Demian Obregon; Ellisa Carla Parker-Athill; Jun Tan; Tanya Murphy
Journal:  Neuropsychiatry (London)       Date:  2012-08

Review 7.  Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Authors:  J C Felger; F E Lotrich
Journal:  Neuroscience       Date:  2013-05-03       Impact factor: 3.590

Review 8.  Biological risk factors for late life depression.

Authors:  Henning Tiemeier
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

9.  A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial.

Authors:  Lisa M Thornton; Barbara L Andersen; Tammy A Schuler; William E Carson
Journal:  Psychosom Med       Date:  2009-07-21       Impact factor: 4.312

10.  The effects of antidepressant treatment on serum cytokines and nutritional status in hemodialysis patients.

Authors:  Sang-Kyu Lee; Hong-Seock Lee; Tae-Byeong Lee; Do-Hoon Kim; Ja-Ryong Koo; Yong-Ku Kim; Bong-Ki Son
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.